Halozyme Therapeutics
HALO
#1813
Rank
HK$92.09 B
Marketcap
HK$807.80
Share price
0.06%
Change (1 day)
52.81%
Change (1 year)

Halozyme Therapeutics (HALO) - Net assets

Net assets on the balance sheet as of June 2026 : HK$1.12 Billion

According to Halozyme Therapeutics's latest financial reports the company has HK$1.12 Billion in net assets.
A companyโ€™s net assets is the sum of its assets minus the sum of its liabilities.

Halozyme Therapeutics - Net assets on balance sheet (from 2002 to 2024)

Net assets by year

Year Net assets Change
2023-12-31$HK$0.65 B-50.66%
2022-12-31$HK$1.32 B-13.61%
2021-12-31$HK$1.53 B31.16%
2020-12-31$HK$1.17 B63.84%
2019-12-31$HK$0.71 B-63.33%
2018-12-31$HK$1.94 B19.72%
2017-12-31$HK$1.62 B-746.33%
2016-12-31$-HK$0.26 Billion-175.58%
2015-12-31$HK$0.33 B3.91%
2014-12-31$HK$0.32 B-306.92%
2013-12-31$-HK$0.16 Billion-140.93%
2012-12-31$HK$0.37 B347.29%
2011-12-31$HK$84.66 M-46.55%
2010-12-31$HK$0.15 B195.89%
2009-12-31$HK$53.52 M-54.96%
2008-12-31$HK$0.11 B-73.61%
2007-12-31$HK$0.45 B150.91%
2006-12-31$HK$0.17 B27.17%
2005-12-31$HK$0.14 B22.54%
2004-12-31$HK$0.11 B3875.98%
2003-12-31$HK$2.89 M-197.89%
2002-12-31$-HK$2.96 Million-1762.16%
2001-12-31$HK$0.17 M

Net assets for similar companies or competitors

Company Net assets differencediff. Country
Johnson & Johnson
JNJ
HK$639.53 B 56,697.61%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
HK$670.62 B 59,458.46%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
HK$315.89 B 27,955.01%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
HK$622.82 B 55,213.74%๐Ÿ‡ซ๐Ÿ‡ท France
Baxter
BAX
HK$48.46 B 4,204.63%๐Ÿ‡บ๐Ÿ‡ธ USA
MannKind Corp
MNKD
-HK$0.53 Billion-146.81%๐Ÿ‡บ๐Ÿ‡ธ USA